Nathan Weinstein
Stock Analyst at Aegis Capital
(0.28)
# 4,390
Out of 5,157 analysts
59
Total ratings
13.79%
Success rate
-24.81%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $0.75 | +10,553.88% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $400 → $300 | $8.90 | +3,270.79% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.20 | +2,860.04% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $1.45 | +2,313.79% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $1.93 | +210.88% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $3.40 | +782.35% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $11.94 | -16.25% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $17.22 | +184.55% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $63,000 → $1,800 | $1.97 | +91,270.56% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $8.51 | +25,281.90% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.95 | +6,053.85% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.57 | +1,642.77% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $26.96 | +107.72% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $4.06 | +565.02% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $0.89 | +3,823.77% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.39 | +763.31% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $26.57 | +182.27% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $2.02 | +4,256.44% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.60 | +30,020.48% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $12.71 | +962.16% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.65 | +110.53% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $16.37 | +1,243.92% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $2.94 | +189.12% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $0.75
Upside: +10,553.88%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400 → $300
Current: $8.90
Upside: +3,270.79%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.20
Upside: +2,860.04%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $1.45
Upside: +2,313.79%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $1.93
Upside: +210.88%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $3.40
Upside: +782.35%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $11.94
Upside: -16.25%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $17.22
Upside: +184.55%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $63,000 → $1,800
Current: $1.97
Upside: +91,270.56%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $8.51
Upside: +25,281.90%
Dec 7, 2021
Initiates: Buy
Price Target: $120
Current: $1.95
Upside: +6,053.85%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.57
Upside: +1,642.77%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $26.96
Upside: +107.72%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $4.06
Upside: +565.02%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $0.89
Upside: +3,823.77%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.39
Upside: +763.31%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $26.57
Upside: +182.27%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $2.02
Upside: +4,256.44%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $0.60
Upside: +30,020.48%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $12.71
Upside: +962.16%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $6.65
Upside: +110.53%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $16.37
Upside: +1,243.92%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $2.94
Upside: +189.12%